Skip to content

Clinical trials

Terminated Phase 3 Ovarian Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 3 Status: Terminated Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20062
20091
20112
20121
20131
20141
20151
20161
20181
20192
20201
20212
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
Pfizer2
AGO Research GmbH1
AbbVie1
Aravive, Inc.1
Endocyte1
Ente Ospedaliero Ospedali Galliera1
European Organisation for Research and Treatment of Cancer - EORTC1
Gynecologic Oncology Group1
InterMune1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms23
Carcinoma, Ovarian Epithelial5
Fallopian Tube Neoplasms5
Neoplasms3
Breast Neoplasms2
Carcinoma2
Blast Crisis1
Brenner Tumor1
Burkitt Lymphoma1
Congenital Abnormalities1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.